Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$14.2
Market cap
$177.86M
P/E Ratio
41.76
Dividend/share
$0.15
EPS
$0.34
Enterprise value
$176.63M
LifeVantage Corporation is a pioneer in Nutrigenomics - a new science dedicated to biohacking the human aging code. The Company engages in the identification, research, development and distribution of advanced
Highlights
LFVN's EPS has soared by 70% YoY and by 42% QoQ
The net income has soared by 62% YoY and by 41% from the previous quarter
The company's equity rose by 7% QoQ but it fell by 5% YoY
The price to earnings (P/E) is 103% more than the 5-year quarterly average of 20.6 and 52% more than the last 4 quarters average of 27.5
LFVN's quick ratio is down by 10% since the previous quarter and by 6% year-on-year
Key stats
What are the main financial stats of LFVN
Market
Valuations
Earnings
Shares outstanding
12.53M
Market cap
$177.86M
Enterprise value
$176.63M
Price to earnings (P/E)
41.76
Price to book (P/B)
6.4
Price to sales (P/S)
0.88
EV/EBIT
28.96
EV/EBITDA
16.08
EV/Sales
0.9
Revenue
$196.01M
EBIT
$6.1M
EBITDA
$10.98M
Free cash flow
$5.39M
Per share
Balance sheet
Liquidity
EPS
$0.34
Free cash flow per share
$0.44
Book value per share
$2.22
Revenue per share
$16.12
TBVPS
$5.03
Total assets
$61.46M
Total liabilities
$33.76M
Debt
$13.36M
Equity
$27.7M
Working capital
$16.74M
Debt to equity
0.48
Current ratio
1.76
Quick ratio
0.8
Net debt/EBITDA
-0.11
Margins
Efficiency
Dividend
EBITDA margin
5.6%
Gross margin
79.2%
Net margin
2.1%
Operating margin
3.1%
Return on assets
6.7%
Return on equity
15.3%
Return on invested capital
17.1%
Return on capital employed
15.5%
Return on sales
3.1%
Dividend yield
1.06%
DPS
$0.15
Payout ratio
44.1%
LFVN stock price
How has the Lifevantage stock price performed over time
Intraday
7.9%
1 week
2.68%
1 month
14.24%
1 year
157.71%
YTD
136.67%
QTD
17.55%
Financial performance
How have Lifevantage's revenue and profit performed over time
Revenue
$196.01M
Gross profit
$155.26M
Operating income
$6.15M
Net income
$4.13M
Gross margin
79.2%
Net margin
2.1%
The company's operating margin has surged by 82% YoY and by 41% QoQ
The net margin has soared by 75% YoY and by 40% from the previous quarter
LFVN's operating income has soared by 65% year-on-year and by 42% since the previous quarter
The net income has soared by 62% YoY and by 41% from the previous quarter
Growth
What is Lifevantage's growth rate over time
Valuation
What is Lifevantage stock price valuation
P/E
41.76
P/B
6.4
P/S
0.88
EV/EBIT
28.96
EV/EBITDA
16.08
EV/Sales
0.9
The price to earnings (P/E) is 103% more than the 5-year quarterly average of 20.6 and 52% more than the last 4 quarters average of 27.5
LFVN's EPS has soared by 70% YoY and by 42% QoQ
The price to book (P/B) is 94% higher than the 5-year quarterly average of 3.3 and 78% higher than the last 4 quarters average of 3.6
The company's equity rose by 7% QoQ but it fell by 5% YoY
The P/S is 76% more than the 5-year quarterly average of 0.5 and 76% more than the last 4 quarters average of 0.5
The revenue has declined by 8% year-on-year and by 2.1% since the previous quarter
Efficiency
How efficient is Lifevantage business performance
LFVN's return on equity has surged by 94% year-on-year and by 43% since the previous quarter
The company's return on assets has surged by 76% YoY and by 43% QoQ
The return on invested capital has surged by 66% year-on-year and by 39% since the previous quarter
LFVN's ROS has soared by 63% YoY and by 41% QoQ
Dividends
What is LFVN's dividend history
DPS
$0.15
Dividend yield
1.06%
Payout ratio
44.1%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Lifevantage financials performed over time
Lifevantage's total assets is 82% more than its total liabilities
The company's total liabilities fell by 10% YoY
LFVN's quick ratio is down by 10% since the previous quarter and by 6% year-on-year
The debt is 52% less than the equity
The company's debt to equity fell by 8% QoQ
The company's equity rose by 7% QoQ but it fell by 5% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.